Core Laboratories Inc
(CLB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,442 | 19,658 | 12,968 | 5,317 | -1,839 |
| Depreciation Amortization | 4,044 | 17,161 | 13,088 | 8,917 | 4,557 |
| Income taxes - deferred | 936 | 433 | -1,807 | 530 | 1,698 |
| Accounts receivable | -4,024 | -10,078 | -3,390 | -2,202 | -2,831 |
| Accounts payable and accrued liabilities | -7,078 | 15,374 | 4,288 | 5,062 | 3,693 |
| Other Working Capital | -19,604 | -25,019 | -26,394 | -18,912 | -7,655 |
| Other Operating Activity | 20,115 | 7,427 | 12,992 | 7,183 | 7,667 |
| Operating Cash Flow | $-3,169 | $24,956 | $11,745 | $5,895 | $5,290 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,128 | -8,327 | -7,769 | -5,212 | -2,216 |
| Net Acquisitions | N/A | 240 | 240 | 240 | N/A |
| Purchase Sale Intangibles | 90 | -29 | -27 | -42 | -13 |
| Other Investing Activity | 90 | 4,231 | 2,615 | 2,615 | 2,644 |
| Investing Cash Flow | $-2,038 | $-3,856 | $-4,914 | $-2,357 | $428 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 24,000 | 116,000 | 44,000 | 29,000 | 15,000 |
| Debt Repayment | -16,000 | -131,000 | -49,000 | -31,000 | -14,000 |
| Common Stock Repurchased | -1 | -3,903 | -2,311 | -2,166 | -1,920 |
| Dividend Paid | -466 | -1,853 | -1,389 | -926 | -463 |
| Other Financing Activity | -1,469 | -2,619 | -2,102 | -1 | -1 |
| Financing Cash Flow | $6,064 | $-23,375 | $-10,802 | $-5,093 | $-1,384 |
| Beginning Cash Position | 15,428 | 17,703 | 17,703 | 17,703 | 17,703 |
| End Cash Position | 16,285 | 15,428 | 13,732 | 16,148 | 22,037 |
| Net Cash Flow | $857 | $-2,275 | $-3,971 | $-1,555 | $4,334 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,169 | 24,956 | 11,745 | 5,895 | 5,290 |
| Capital Expenditure | -2,208 | -10,216 | -8,195 | -5,493 | -2,297 |
| Free Cash Flow | -5,377 | 14,740 | 3,550 | 402 | 2,993 |